{"id":"W2062448901","doi":"10.1185/03007995.2014.944973","title":"Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Nilotinib; Imatinib; Internal medicine; Adverse effect; Incidence (geometry); Imatinib mesylate; Quality of life (healthcare); Chronic myelogenous leukemia; Philadelphia chromosome; Bosutinib; Tyrosine-kinase inhibitor; Myeloid leukemia; Gastroenterology; Leukemia; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003054628,0.0003648636,0.001321172,0.0006497792,0.0001038297,0.000005425657,0.0002844424,0.0003169626,0.0001738233],"category_scores_gemma":[0.01392786,0.0002759545,0.0002170259,0.0008341206,0.00040634,0.0001283114,0.0001505877,0.001158139,0.000009615326],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01060748,"about_ca_system_score_gemma":0.01212546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00329846,"about_ca_topic_score_gemma":0.0009647705,"domain_scores_codex":[0.9933997,0.001022089,0.001875379,0.0007241227,0.001830825,0.001147875],"domain_scores_gemma":[0.9945451,0.002912696,0.0005704781,0.0004747855,0.000418944,0.001077997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03567862,0.02287272,0.2401271,0.02124262,0.0006992878,0.0000505702,0.004743189,0.0003681284,0.001914419,0.0003667719,0.0023319,0.6696047],"study_design_scores_gemma":[0.1462065,0.03814866,0.7739416,0.02198563,0.00001887158,0.000006909671,0.0001087202,0.01854683,0.0003885219,0.0002067662,0.00007874313,0.000362241],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933808,0.002017257,0.00004479814,0.0006875753,0.0002869749,0.003305965,0.0002362914,0.00002082199,0.00001951289],"genre_scores_gemma":[0.9920892,0.006213161,0.00003493941,0.00003443248,0.0002459089,0.0002322914,0.001100535,0.00004343415,0.000006117594],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6692425,"threshold_uncertainty_score":0.9999692,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09152452362728754,"score_gpt":0.4554350368855942,"score_spread":0.3639105132583066,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}